@julkin - WinSanTor is a company but the drug they make is what this discussion is about. Here's an article about it.

"Treating Peripheral Neuropathy
The hope is that these new findings support the potential for select anti-muscarinic drugs already on the market, like pirenzepine, to be repurposed as a possible preventative, and even treatment, for the clinical effects of peripheral neuropathy, which, for patients, has been largely been a matter of pain relief, and associated with significant health care costs." --- Blocking Anti-Muscarinic Drugs May Reverse PN: https://winsantor.com/anti-muscarinic-drugs-may-reverse-peripheral-neuropathy/

WinSanTor’s lead compound, WST-057 is the topical containing pirenzepene - https://winsantor.com/pipeline/
More info on the Phase 2 clinical trial page - https://clinicaltrials.gov/ct2/show/NCT04005287